Lisanti Capital Growth’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Lisanti Capital Growth’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-11,000	Closed	-$579K	–	119
2016 Q4	$579K	Buy	+11,000	New	+$533K	0.7%	73
2016 Q1	–	Sell	-26,385	Closed	-$1.28M	–	114
2015 Q4	$1.28M	Sell	26,385 -19,231	-42%	-$855K	1.34%	28
2015 Q3	$1.82M	Sell	45,616 -14,229	-24%	-$621K	1.64%	16
2015 Q2	$2.4M	Sell	59,845 -21,485	-26%	-$741K	1.73%	10
2015 Q1	$2.66M	Buy	81,330 +500	+0.6%	+$13.8K	1.52%	16
2014 Q4	$2.08M	Buy	+80,830	New	+$1.92M	1.04%	49

Other funds holding SYNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

PIM

Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Lisanti Capital Growth's SYNH Position: Q1 2017 in Review

Lisanti Capital Growth sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2017, closing a stake of 11,000 shares — an estimated $579K sold.

Lisanti Capital Growth first reported a position in SYNH in Q4 2014 and held it in 6 quarters. The position peaked at $2.66M in Q1 2015. 232 funds tracked by Wall St. Rank hold SYNH as of Q1 2017.

Lisanti Capital Growth reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2017 after selling out during the quarter.
Lisanti Capital Growth sold 11,000 Syneos Health, Inc. Class A Common Stock shares in Q1 2017, an estimated $579K.
Lisanti Capital Growth first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 6 quarters.
Lisanti Capital Growth's Syneos Health, Inc. Class A Common Stock position peaked at $2.66M in Q1 2015.
232 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2017.

Based on Lisanti Capital Growth's 13F filing for Q1 2017, filed 12 May 2017.